New Zealand reports first death linked to Pfizer COVID-19 vaccine

0
21
Panorama of a city business district with office buildings and skyscrapers and superimposed data, charts and diagrams related to stock market, currency exchange and global finance. Blue line graphs with numbers and exchange rates, candlestick charts and financial figures fill the image with a glowing light. Sunset light.
imageCoronavirus News16 minutes ago (Aug 30, 2021 13:45)

© Reuters. FILE PHOTO: Pfizer logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. Picture taken March 16, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

By Praveen Menon

WELLINGTON (Reuters) -New Zealand reported its first recorded death linked to U.S. drugmaker Pfizer (NYSE:PFE)’s COVID-19 vaccine, the health ministry said on Monday, after a woman suffered a rare side-effect leading to inflammation of the heart muscle.

The report comes as the country battles an outbreak of the Delta variant after nearly six months of being virus free. It followed a review by an independent panel monitoring the safety of the vaccines.

“This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine,” the ministry said in a statement, without giving the woman’s age.

The vaccine monitoring panel attributed the death to myocarditis, a rare, but known, side-effect of the Pfizer vaccine, the ministry added.

Myocarditis is an inflammation of the heart muscle that can limit the organ’s ability to pump blood and can cause changes in heartbeat rhythms.

Pfizer said it  recognised there could be rare reports of myocarditis after vaccinations, but such side-effects were extremely rare.

“Pfizer takes adverse events that are potentially associated with our vaccine very seriously,” it told Reuters.

“We closely monitor all such events and collect relevant information to share with worldwide regulatory authorities.”  

The health ministry said other medical issues at the same time could have influenced the outcome after vaccination.

But the vaccine’s benefit outstripped risks from side effects, it added.

“The benefits of vaccination with the Pfizer COVID-19 vaccine continue to greatly outweigh the risk of both COVID-19 infection and vaccine side-effects, including myocarditis.”

Regulators in the United States, the European Union and the World Health Organization have said that mRNA vaccines by Pfizer and partner BioNTech and by Moderna (NASDAQ:MRNA) are associated with rare cases of inflammation of the heart muscle or of the lining around the heart but that the benefits outweighed any risks.

The cases, affecting mainly younger men, tend to be mild and are treatable but can lead to serious illness, WHO has said.

The EU’s drug regulator said on July 9 that five people had died due to the side-effect after receiving either of the two mRNA vaccines in the European Economic Area, all of whom were elderly or had other diseases. More than 200 million mRNA doses have been administered in the region.

New Zealand has provisionally approved use of the Pfizer/BioNTech, Janssen and AstraZeneca (NASDAQ:AZN) vaccines, but only the Pfizer-produced vaccine has been approved for rollout to the public.

Monday’s 53 new cases took New Zealand’s tally of infections in the current outbreak to 562, amid a nationwide lockdown enforced this month to limit spread of the Delta variant.

New Zealand reports first death linked to Pfizer COVID-19 vaccine

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

LEAVE A REPLY

Please enter your comment!
Please enter your name here